Ante Vukojević

Dr. Ante Vukojević

Department of Ophthalmology, UHC Sestre Milosrdnice, Zagreb, Zagreb, Grad, Croatia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
IKInes Matoc Kasumovic
Ines Matoc Kasumovic
KKKim Kasa
Kim Kasa
AKArmin Kasumovic
Armin Kasumovic
APAnte Prpić
Ante Prpić
AVAnte Vukojević
Ante Vukojević
ZVZoran Vatavuk
Zoran Vatavuk
The aim of this study is to assess the effectiveness of a 12-week doxycycline treatment for thyroid eye disease (TED), an autoimmune condition associated with thyroid dysfunction. In this randomized controlled clinical trial, 82 patients were randomly assigned at a 1:1 ratio to receive doxycycline (50 mg) or to undergo no treatment. Various metrics, including margin reflex distance (MRD1 and MRD2), eyelid aperture, levator muscle function, lagophthalmos, proptosis, ocular motility, diplopia, and Graves’ ophthalmopathy-specific quality-of-life (GO-QOL) scale scoring were assessed. Exclusion criteria were uncontrolled systemic diseases, tetracycline allergies, pregnancy, lactation, or age below 18. The mean age was 51.6 years (SD), 87.8% of participants were female, and all were Caucasians. By week 12, the doxycycline group exhibited a significant improvement rate based on MRD2 (from 4 to 15 participants with physiological findings), clinical activity score (from 7 to 35 participants with non-active disease), and GO-QOL (from 51.22% to 70.73% of participants with a good life quality). Doxycycline showcased anti-inflammatory and immunomodulatory effects in treating TED, suggesting its potential efficacy for TED and other orbit inflammatory conditions. However, these results warrant further validation through future research involving extended follow-up periods and larger cohorts.

17 July 2025 in Life
Verified
Journal Article
Open access
PDF file
IOIvana Oreskovic
Ivana Oreskovic
MRMaja Malenica Ravlić Maja Malenica Ravlić
Maja Malenica Ravlić Maja Malenica Ravlić
LKLana Knežević Lana Knežević
Lana Knežević Lana Knežević
BMBlanka Doko Mandić
Blanka Doko Mandić
GMGoran Marić
Goran Marić
JHJelena Škunca Herman
Jelena Škunca Herman
Purpose: The aim of this study was to compare the one-year efficacy of three spectacle lens designs, highly aspherical lenslets (HALs), horizontally asymmetric peripheral defocus (HAPD) lenses, and standard single vision lenses (SVLs) in slowing myopia progression in school-aged children. Methods: In this prospective, non-randomized study, 57 children, aged 8–17 years, were grouped based on the type of lenses worn: HAL (n = 16), HAPD (n = 21), or SVL (n = 20). Comprehensive ophthalmologic examinations were performed at baseline, 6 months, and 12 months. Outcome measures included spherical equivalent refraction (SER), spherical refraction (SR), cylindrical refraction (CR), and axial length (AL). Data were analyzed using non-parametric tests with significance set at p < 0.05. Results: All groups showed some progression in SER and AL over 12 months. The HAL group demonstrated the smallest median SER change (−0.3 D), compared to HAPD (−0.5 D) and SVL (−0.4 D), though group differences were not statistically significant (p = 0.111). Axial elongation was significantly lower in the HAL group (0.1 mm, IQR: 0.0–0.2 mm) compared to HAPD and SVL (both 0.2 mm, p < 0.0001). CR remained stable in all groups, with no clinically meaningful changes. The HAPD groups showed no advantages over SVL in any parameter. Conclusions: Among the three lens types studied, HAL lenses were the most effective in reducing both refractive and axial myopia progression over 12 months. These findings support their use as a reliable intervention in pediatric myopia control.

26 November 2025 in Medicina
Verified
Journal Article
Open access
PDF file
FBFreja Bagatin
Freja Bagatin
AVAnte Vukojević
Ante Vukojević
KRKarla Ranđelović
Karla Ranđelović
IRIvana Radman
Ivana Radman
RIRenata Ivekovic
Renata Ivekovic
ZVZoran Vatavuk
Zoran Vatavuk
Background and Objectives: Corneal cross-linking (CXL) is the standard treatment for progressive keratoconus, but delayed epithelial healing remains a concern, increasing infection risk and patient discomfort. Studies suggest that insulin may promote corneal epithelial cell migration and proliferation, potentially accelerating wound healing. Its benefit has been observed in neurotrophic keratitis and diabetic epithelial defects, and it may offer similar effects post-CXL. Our objective is to evaluate the effect of topical insulin on epithelial healing after CXL in a small case series. Materials and Methods: Eight patients undergoing CXL for keratoconus were divided into two groups (n = 4 each). The insulin group received topical insulin eye drops (1 IU/mL in Systane®) five times daily, in addition to standard postoperative care. The control group received Systane® alone with the same regimen. Daily follow-up included slit-lamp exam, anterior segment OCT, and photodocumentation until epithelial defect closure. Results: Baseline parameters (central corneal thickness, keratoconus stage, Schirmer test, tear break up test) were comparable. While not statistically significant, the insulin group showed numerically smaller epithelial defects on day 2, suggesting a possible trend toward faster healing. By day 3, re-epithelialization was complete in all patients. Pain decreased over time in both groups without significant differences. No adverse effects were noted. Conclusions: Topical insulin may modestly accelerate epithelial healing after CXL, as suggested by smaller defects on day 2 in the insulin group. Although results were not statistically significant, the trend warrants further investigation in larger studies.

14 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAnte Vukojević
Ante Vukojević
MVMarija Vukojević
Marija Vukojević
TJTomislav Jukić
Tomislav Jukić
IPIgor Petriček
Igor Petriček
KMKrešimir Mandić
Krešimir Mandić
NVNenad Vukojević
Nenad Vukojević
Hereditary hemochromatosis (HH) is an inherited iron metabolism disorder. It is caused by an autosomal recessive disorder resulting from a C28Y8 HFE gene mutation. Mutations in the HFE gene may result in iron accumulation and oxidative stress in the retina, resulting in macular degeneration. This article describes two patients with HH who developed vision difficulties. Both patients were subjected to a retinal exam, multimodal imaging, and electrodiagnostic techniques, which revealed structural and functional degeneration of the central macula. Fundus photography, fluorescein angiography (FA), and fundus autofluorescence (FAF) revealed changes at the level of the retinal pigment epithelium (RPE) in the center of the macula, while optical coherence tomography (OCT) revealed subfoveal accumulation of hyperreflective material at and below the RPE. The multifocal electroretinogram (mfERG) confirmed a decreased cone response, whereas the full-field electroretinogram (ERG) revealed no pathological findings. In addition, patients underwent genetic testing, which ruled out the possibility of hereditary macular dystrophy. Considering macula findings and the nature of the patients' primary illness, we believe that the higher concentration and accumulation of iron and photoreceptor metabolic products have led to dysfunction in the RPE, which has led to morphological and functional changes in the macula.

23 July 2025 in Life
Verified
Journal Article
Open access
PDF file
MRMarin Radmilovic
Marin Radmilovic
GMGoran Marić
Goran Marić
AVAnte Vukojević
Ante Vukojević
MGMia Zorić Geber
Mia Zorić Geber
ZVZoran Vatavuk
Zoran Vatavuk
We report a case of herpes simplex virus type 1 (HSV-1) anterior uveitis evolving into an acute iris transillumination-like syndrome with secondary pigmentary glaucoma, highlighting diagnostic challenges and treatment considerations. A 61-year-old immunocompetent woman presented with unilateral anterior uveitis characterized by keratic precipitates and mild anterior chamber inflammation. The condition was initially treated with topical and subconjunctival corticosteroids without antiviral therapy. After an initial resolution of symptoms, upon the cessation of treatment, the patient developed features resembling unilateral acute iris transillumination (UAIT) syndrome with elevated intraocular pressure, diffuse pigment dispersion, and progressive iris transillumination defects. Aqueous polymerase chain reaction (PCR) testing confirmed the presence of HSV-1. Despite the initiation of antiviral therapy, the condition progressed to severe pigmentary glaucoma, with unreliable intraocular pressure measurements due to prior LASIK surgery. Cataract extraction, pars plana vitrectomy, and Ahmed valve implantation were performed, with only partial recovery of visual acuity. This case illustrates that HSV-1 uveitis can mimic or transition into a UAIT-like syndrome, possibly due to steroid use without concurrent antiviral treatment, which may exacerbate viral replication and damage to the iris pigment epithelium. Aqueous PCR testing aids in differential diagnosis, but indicative medical history and clinical findings should remain instrumental. Clinicians should maintain a high index of suspicion for herpetic etiology in anterior uveitis cases and initiate prompt antiviral treatment to prevent potentially sight-threatening complications.

17 July 2025 in Life
Verified
Journal Article
Open access
PDF file
JHJelena Škunca Herman
Jelena Škunca Herman
DZDARIO-JOSIP ZIVKOVIĆ
DARIO-JOSIP ZIVKOVIĆ
IOIvana Oreskovic
Ivana Oreskovic
LKLana Knežević Lana Knežević
Lana Knežević Lana Knežević
MRMaja Malenica Ravlić Maja Malenica Ravlić
Maja Malenica Ravlić Maja Malenica Ravlić
ZVZoran Vatavuk
Zoran Vatavuk
Background: Arachnoid cysts are typically benign and asymptomatic, but large cysts can exert a mass effect on adjacent neural structures. Based on the available literature, no cases of cortical visual impairment (CVI) in an adolescent caused by posterior fossa arachnoid cysts have been reported. Case presentation: We report the case of a previously healthy 16-year-old girl who presented with sudden and rapidly progressive bilateral visual loss due to a large retrocerebellar arachnoid cyst. She reported blurred vision, tunnel vision-like, and decreased visual acuity. Although neuro-ophthalmologic and imaging workup revealed no damage to the anterior visual pathways, she exhibited progressive visual decline. Functional tests confirmed bilateral cortical visual impairment: pattern-reversal visual evoked potentials (VEPs) showed preserved and symmetric P100 latencies and amplitudes, while automated perimetry revealed bilateral concentric visual field constriction with preserved central islands. Following cystoperitoneal drainage, her vision rapidly and completely recovered. Conclusions: To the best of our knowledge, this is the first reported case of reversible CVI in an adolescent caused by a posterior fossa arachnoid cyst without intracranial pressure (ICP) elevation or optic nerve involvement, and with tunnel vision-like. Our findings emphasize the role of posterior fossa lesions in visual dysfunction and highlight the potential reversibility of cortical visual loss when timely decompression is achieved. This case underscores the importance of including posterior fossa lesions in the differential diagnosis of unexplained bilateral visual loss, even in the absence of elevated intracranial pressure or anterior visual pathway involvement.